Mucolytics in adults
One trial compared a mucolytic (bisolvon linctus) 5 mg three times daily for an average of 4 days with placebo. Active treatment reduced cough frequency and symptom scores on days 4 and 8. The NNTB was 15 and adverse effects were not reported.